Taking estrogen without progestin for four or more years after menopause increases women's chances of developing ovarian cancer, but women who take both hormones do not appear to be at greater risk ...

Postmenopausal patients with ovarian or endometrial cancer who received conjugated equine estrogen may have increased mortality rates. For patients with ovarian and endometrial cancer, receiving ...

CHICAGO — Cancer risk among women varied based on the type of menopausal hormone therapy they used, according to randomized study results scheduled for presentation at ASCO Annual Meeting. Perspective ...

CHICAGO -- Use of conventional hormonal therapy for menopausal symptoms doubled the long-term risk of ovarian cancer and the risk of dying of the disease, according to an analysis of Women's Health ...

A small percentage of ovarian cancers are hereditary, driven by inherited mutations in genes such as BRCA1 and BRCA2. Most ovarian cancers are “sporadic,” however, meaning they are driven by mutations ...

Evidence shows that birth control pills containing the hormones estrogen and progestin can increase the risk of different types of cancers and decrease the risk of others.  Since 1999, the World ...

Trastuzumab Deruxtecan in Patients With HER2-Mutant Metastatic Non–Small-Cell Lung Cancer: Primary Results From the Randomized, Phase II DESTINY-Lung02 Trial The ASTRRA trial highlights both the power ...

AMH versus AFC in women with cancer: an abstract from the 2026 Annual Congress of the International Society of Gynecological ...